HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,541,007 | -8.4% | 29,431 | -28.8% | 0.06% | -12.3% |
Q1 2024 | $1,681,955 | +6.1% | 41,346 | -3.6% | 0.06% | -4.4% |
Q4 2023 | $1,585,732 | -6.2% | 42,904 | -3.0% | 0.07% | -26.9% |
Q3 2023 | $1,690,426 | -6.7% | 44,252 | -11.9% | 0.09% | -4.1% |
Q2 2023 | $1,811,471 | +28.4% | 50,221 | +36.0% | 0.10% | +11.5% |
Q1 2023 | $1,410,280 | +9.1% | 36,928 | +62.6% | 0.09% | +3.6% |
Q4 2022 | $1,292,313 | +43.4% | 22,712 | -0.3% | 0.08% | +29.2% |
Q3 2022 | $901,000 | -11.8% | 22,788 | -1.9% | 0.06% | 0.0% |
Q2 2022 | $1,022,000 | -5.8% | 23,230 | -14.7% | 0.06% | +41.3% |
Q1 2022 | $1,085,000 | -11.0% | 27,218 | -10.2% | 0.05% | +15.0% |
Q4 2021 | $1,219,000 | -12.0% | 30,312 | -11.0% | 0.04% | -14.9% |
Q3 2021 | $1,386,000 | +171.2% | 34,067 | +203.5% | 0.05% | +176.5% |
Q2 2021 | $511,000 | +12.3% | 11,223 | +2.8% | 0.02% | 0.0% |
Q1 2021 | $455,000 | -14.3% | 10,916 | -12.2% | 0.02% | -26.1% |
Q4 2020 | $531,000 | -2.2% | 12,427 | -80.3% | 0.02% | -11.5% |
Q2 2016 | $543,000 | -10.8% | 62,971 | -2.1% | 0.03% | -18.8% |
Q1 2016 | $609,000 | -56.2% | 64,341 | -19.8% | 0.03% | -51.5% |
Q4 2015 | $1,389,000 | +28.7% | 80,177 | -0.2% | 0.07% | +8.2% |
Q3 2015 | $1,079,000 | – | 80,356 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,816,162 | $195,784,000 | 9.33% |
BB BIOTECH AG | 5,846,564 | $57,764,000 | 2.74% |
QVT Financial LP | 4,556,090 | $45,014,000 | 2.44% |
Parametrica Management Ltd | 29,578 | $292,000 | 2.21% |
SECTORAL ASSET MANAGEMENT INC | 4,389,682 | $43,370,000 | 1.84% |
Belmont Global Advisors, Inc. | 257,000 | $2,539,000 | 1.83% |
HARVEY CAPITAL MANAGEMENT INC | 394,550 | $3,898,000 | 1.40% |
Lombard Odier Asset Management (USA) Corp | 1,350,000 | $13,338,000 | 0.70% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 6,199,685 | $61,253,000 | 0.63% |
Callan Capital, LLC | 199,230 | $1,968,000 | 0.53% |